Radioiodine therapy: a dosimetric study in a patient with DTC after rhTSH stimulation

被引：0
|
作者：
Mazzaglia, S. [1 ,2 ]
Tonghi, L. Barone [2 ]
Gueli, A. M. [1 ,3 ]
Tuve, C. N. [1 ,3 ]
Pellegriti, G. [1 ,4 ]
机构：
[1] Univ Catania, Dept Med Surg & Adv Technol GF Ingrassia DGFI, Specializat Sch Med Phys, Catania, Italy
[2] ARNAS Garibaldi Catania, Med Phys, Catania, Italy
[3] Univ Catania, Deparment Phys & Astron, Catania, Italy
[4] ARNAS Garibaldi Catania, Endocrinol, Catania, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)32193-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1773
引用
收藏
页码：S958 / S958
页数：1
相关论文
共 50 条
  • [1] Radiation protection impact of radioiodine therapy for hyperthyroidism after a patient specific dosimetric study
    Canzi, C.
    Longari, V.
    Castellani, M.
    Zito, F.
    Voltini, F.
    Benti, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S371 - S371
  • [2] Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH
    Lassmann, M
    Hänscheid, H
    Reiners, C
    Thomas, SR
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 900 - 901
  • [3] Radiation protectio impact of radioiodine therapy for hyperthyroidism after a patient specific dosimetric study
    Canzi, C.
    Longari, V.
    Castellani, M.
    Buffoni, F.
    Zito, F.
    Voltini, F.
    Benti, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S333 - S334
  • [4] Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH - Reply
    de Keizer, B
    de Klerk, JMH
    Konijnenberg, MW
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 901 - 901
  • [5] Radioiodine therapy after rhTSH stimulation in patients with metastatic biologically aggressive or critical localization of thyroid cancer
    Bombardieri, E.
    Seregni, E.
    Pallotti, F.
    Villano, C.
    Aliberti, G.
    Mattavelli, F.
    Collini, P.
    Maccauro, M.
    Castellani, M. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S65 - S65
  • [6] A patient-specific dosimetric method for the radioiodine therapy of the autonomous nodule
    Matheoud, R
    Canzi, C
    Reschini, E
    Zito, F
    Voltini, F
    Lambertini, R
    Gerundini, P
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 983 - 983
  • [7] Thyroid cancer and ablative radioiodine treatment after rhTSH stimulation : When serum thyroglobulin level be evaluated?
    Morel, O.
    Girault, S.
    Berthelot, C.
    Giraud, P.
    Jeanguillaume, C.
    Jallet, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S353 - S354
  • [8] Prognostic significance of early thyroglobulin release after radioiodine therapy under rhTSH for thyroid cancer
    Eberle, M.
    Gall, E.
    Guillemard, S.
    Espitalier, C.
    Raingeard, I.
    Cartier, C.
    Jarlier, M.
    De Forges, H.
    Kotzki, P.
    Deshayes, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S326 - S327
  • [9] Thyroglobulin (Tg) response to multiple rhTSH-aided radioiodine treatments (rhTSH-RITs) in patients with advanced differentiated thyroid carcinoma (DTC)
    Handkiewicz-Junak, Daria
    Marlowe, Robert
    Roskosz, Jozef
    Hasse-Lazar, Kornelia
    Szpak-Ulczok, Sylwia
    Jarzab, Barbara
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [10] Metastatic differentiated thyroid cancer in paediatric patients - radioiodine treatment after thyroid hormone withdrawal or rhTSH stimulation
    Handkiewicz-Junak, D.
    Kropinska, A.
    Ledwon, A.
    Roskosz, J.
    Kula, D.
    Kluczewska, A.
    Olczyk, T.
    Paliczka, E.
    Puch, Z.
    Jarzab, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S120 - S121
12345